- Home
- ORC vs RVNC Comparison
ORC vs RVNC Comparison
Compare ORC & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- RVNC
- Stock Information
- Founded
- ORC 2010
- RVNC 1999
- Country
- ORC United States
- RVNC United States
- Employees
- ORC N/A
- RVNC N/A
- Industry
- ORC Real Estate Investment Trusts
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- RVNC Health Care
- Exchange
- ORC Nasdaq
- RVNC Nasdaq
- Market Cap
- ORC 620.3M
- RVNC 599.6M
- IPO Year
- ORC 2013
- RVNC 2014
- Fundamental
- Price
- ORC $7.81
- RVNC $4.17
- Analyst Decision
- ORC Buy
- RVNC Buy
- Analyst Count
- ORC 2
- RVNC 10
- Target Price
- ORC $9.50
- RVNC $10.23
- AVG Volume (30 Days)
- ORC 2.0M
- RVNC 2.8M
- Earning Date
- ORC 10-24-2024
- RVNC 11-07-2024
- Dividend Yield
- ORC 18.44%
- RVNC N/A
- EPS Growth
- ORC N/A
- RVNC N/A
- EPS
- ORC 1.01
- RVNC N/A
- Revenue
- ORC $75,695,000.00
- RVNC $256,945,000.00
- Revenue This Year
- ORC N/A
- RVNC $20.36
- Revenue Next Year
- ORC N/A
- RVNC $31.66
- P/E Ratio
- ORC $7.72
- RVNC N/A
- Revenue Growth
- ORC N/A
- RVNC 25.82
- 52 Week Low
- ORC $7.07
- RVNC $2.30
- 52 Week High
- ORC $9.08
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- ORC 49.44
- RVNC 36.84
- Support Level
- ORC $7.66
- RVNC $3.36
- Resistance Level
- ORC $7.88
- RVNC $4.37
- Average True Range (ATR)
- ORC 0.17
- RVNC 0.31
- MACD
- ORC 0.02
- RVNC -0.15
- Stochastic Oscillator
- ORC 70.18
- RVNC 31.03
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.